Inotuzumab ozogamicin for Named Patient Import

Inotuzumab for Indian Patients

Inotuzumab ozogamicin is an FDA approved drug, recommended by Transplant experts and Hematologists globally. This drug has been used for the management of relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Marketed by Pfizer, Inotuzumab ozogamicin is also developed by the same company with the trade name or brand - Besponsa.

Inotuzumab ozogamicin or Besponsa is a patented drug which is yet to be approved in India for commercial distribution by the Indian entities. Therefore trade and invoicing are restricted for this medicine in India. It is available as Besponsa 0.9mg and Besponsa 1mg vials in the US and European markets. For the benefit of Indian Patients, the statutory authorities allow legal imports through Named Patient Licensing avenues.

Inotuzumab ozogamicin in India? We assist to access.

As a patient who is prescribed to be on Besponsa in India, your immediate priority is to get in touch with reliable global sources or suppliers. We as a team have been assisting patients looking for products like Inotuzumab in India. By clearly explaining the documentation process and also assisting in completing the same, we provide complete support. Most importantly, we help patients get in contact with those sources with adequate experience in supplying to Indian patients across the country.

Kindly Email to nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.